Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02091934 · ClinicalTrials.gov registry record · NA
Wavefront-guided PRK vs Wavefront-optimized PRK
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT02091934: Completed NA study, sponsored by Stanford University.
NCT02091934 is a NA study that has completed, run by Stanford University. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02091934, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the results of PRKK surgery when using wavefront-guided excimer laser treatment compared to wavefront optimized excimer laser treatment in patients with nearsightedness with and without astigmatism
Primary Outcome
Uncorrected visual acuity
Interventions
- PROCEDURE Wavefront-guided PRK
- PROCEDURE Wavefront-optimized PRK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2009-04-01 |
| Est. Completion | 2012-03-31 |
| Phase | NA |
What the finished NCT02091934 record still lists
NCT02091934 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Wavefront-guided PRK is the first listed.
NCT02091934 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02091934 about?
NCT02091934 is a clinical study titled "Wavefront-guided PRK vs Wavefront-optimized PRK". The purpose of the study is to compare the results of PRKK surgery when using wavefront-guided excimer laser treatment compared to wavefront optimized excimer laser treatment in patients with nearsightedness with and without astigmatism
What is the current status of trial NCT02091934?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2009-04-01. Estimated completion is 2012-03-31.
What interventions are being tested in trial NCT02091934?
The interventions under investigation include: Wavefront-guided PRK (PROCEDURE), Wavefront-optimized PRK (PROCEDURE).
Who is sponsoring clinical trial NCT02091934?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02091934's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI